000 | 01112 a2200289 4500 | ||
---|---|---|---|
005 | 20250512145727.0 | ||
264 | 0 | _c19721110 | |
008 | 197211s 0 0 eng d | ||
022 | _a0148-916X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBechelli, L M | |
245 | 0 | 0 |
_aWHO experience in the therapeutic control of leprosy. _h[electronic resource] |
260 |
_bInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association _c |
||
300 |
_a885-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aBrazil |
650 | 0 | 4 |
_aDapsone _xtherapeutic use |
650 | 0 | 4 | _aEpidemiologic Methods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeprosy _xdrug therapy |
650 | 0 | 4 | _aPublic Health Administration |
650 | 0 | 4 | _aSocioeconomic Factors |
650 | 0 | 4 |
_aSulfones _xadministration & dosage |
650 | 0 | 4 | _aWorld Health Organization |
773 | 0 |
_tInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association _gvol. 39 _gno. 4 _gp. 885-9 |
|
999 |
_c5172513 _d5172513 |